SPRY
ARS Pharmaceuticals Q4 FY25 Earnings Results
Revenue Performance ARS Pharmaceuticals recorded total revenue of $28.1 million for the fourth quarter of 2025, driven largely by $20.3…
ARS Pharmaceuticals (SPRY) Posts Q4 Loss of $0.42/Share as Revenue Jumps 332% YoY to $28.1M
ARS Pharmaceuticals reports Q4 loss of $0.42/share as revenue surges 332% YoY to $28.1M despite sequential decline from Q3 peak.